Is anti-platelet therapy needed in continuous flow left ventricular assist device patients? A single-centre experience

Abstract

A fluindione regimen without aspirin in long-duration LVAD support appears to not increase thromboembolic events and could lead to a diminished risk of haemorrhagic stroke.